Germline mutations in the von Hippel-Lindau disease (VHL) gene in mainland Chinese families

Journal of Cancer Research and Clinical Oncology

Volumn 134, Issue 11, 2008, Pages 1211-1218

  Zhang, Jin ^a   Huang, Yiran ^a   Pan, Jiahua ^a   Liu, Dongming ^a   Zhou, Lixin ^a   Xue, Wei ^a   Chen, Qi ^a   Dong, Baijun ^a   Xuan, Hanqing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Chinese; Germline mutations; Renal cell carcinoma; von Hippel Lindau disease

Indexed keywords

GENOMIC DNA; NUCLEOTIDE;

ARTICLE; CHINESE; CONTROLLED STUDY; DNA SEQUENCE; FAMILIAL CANCER; FLUORESCENCE; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; GERM LINE; HAPLOTYPE; HUMAN; INTRON; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONSENSE MUTATION; POPULATION GENETICS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; VON HIPPEL LINDAU DISEASE;

AMINO ACID SUBSTITUTION; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DNA; EXONS; FAMILY; FEMALE; GENE AMPLIFICATION; GENE DELETION; GERM-LINE MUTATION; HUMANS; MALE; PEDIGREE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE DELETION; VON HIPPEL-LINDAU DISEASE; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 53749094168     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-008-0399-x     Document Type: Article

References (35)

1. S Ashida M Furihata M Tanimura O Suqita M Yamashita T Miura M Moriyama T Shuin 2003 Molecular detection of von Hippel-Lindau gene mutations in urine and lymph node samples in patients with renal cell carcinoma: potential biomarkers for early diagnosis and postoperative metastatic status J Urol 169 2089 2093
2. S Ashida H Okoda M Chikazawa M Tanimura O Suqita Y Yamamoto S Nakamura M Moriyama T Shuin 2000 Detection of circulating cancer cells with von Hippel-Lindau gene mutation in peripheral blood of patients with renal cell carcinoma Clin Cancer Res 6 3817 3822
3. RE Banks P Tirukonda C Taylor N Hornigold D Astuti D Cohen ER Maher AJ Stanley P Harnden A Joyce M Knowles P Selby 2006 Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer Cancer Res 66 2000 2011
4. D Catapano LA Muscarella V Guarnieri L Zelante VA D'Angelo L D'Agruma 2005 Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management Neurosurgery 56 1215 1221
5. F Chen T Kishida M Yao T Hustad D Glavac M Dean JR Gnarra ML Orcutt FM Duh G Glenn J Green YE Hsia J Lamiell H Li MH Wei L Schmidt K Tory I Kuzmin T Stackhouse F Latif WM Linehan M Lerman B Zbar 1995 Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype Hum Mutat 5 66 75
6. PL Choyke GM Glenn MM Walther NJ Patronas WM Linehan B Zbar 1995 von Hippel-Lindau disease: genetic, clinical, and imaging features Radiology 194 629 642
7. SC Clifford ME Cockman AC Smallwood DR Mole ER Woodward PH Maxwell PJ Ratcliffe ER Maher 2001 Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease Hum Mol Genet 10 1029 1038
8. C Cybulski K Krzystolik A Murgia B Górski T Debniak A Jakubowska M Martella G Kurzawski M Prost I Kojder J Limon P Nowacki L Sagan B Białas J Kałuza M Zdunek A Omulecka D Jaskólski E Kostyk B Koraszewska-Matuszewska O Haus H Janiszewska K Pecold M Starzycka R Słomski M Cwirko A Sikorski B Gliniewicz L Cyryłowski Ł Fiszer-Maliszewska J Gronwald A Tołoczko-Grabarek S Zajaczek J Lubiński 2002 Germline mutations in the von Hippel-Lindau (VHL) gene in patients from Poland: disease presentation in patients with deletions of the entire VHL gene J Med Genet 39 E38
9. C Gallou D Chauveau S Richard D Joly S Giraud S Olschwang N Martin C Saquet Y Chretien A Mejean JM Correas G Benoit P Colombeau JP Grunfeld C Junien C Beroud 2004 Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions Hum Mutat 24 215 224
10. C Her X Wu MD Griswold F Zhou 2003 Human MutS homologue MSH4 physically interacts with von Hippel-Lindau tumor suppressor-binding protein 1 Cancer Res 63 865 872
11. A Hergovich J Lisztwan R Barry P Ballschmieter W Krek 2003 Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHL Nat Cell Biol 5 64 70
12. FJ Hes S McKee MJB Taphoorn P Rehal RB van der Luijt R McMahon JJ van der Smagt D Dow RA Zewald J Whittaker CJM Lips F MacDonald PL Pearson ER Maher 2000 Cryptic von Hippel-Lindau disease: germline mutations in haemangioblastoma only patients J Med Genet 37 939 943
13. FJ Hes RB van der Luijt ALW Janssen RA Zewald GJ de Jong JW Lenders TP Links GPM Luyten RH Sijmons HJ Eussen DJJ Halley CJM Lips PL Pearson AMW van den Ouweland DF Majoor-Krakauer 2007 Frequency of Von Hippel-Lindau germline mutations in classic and non-classic Von Hippel-Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification Clin Genet 72 122 129
14. MA Hoffman M Ohh H Yang JM Klco M Ivan WG Kaelin Jr 2001 von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF Hum Mol Genet 10 1019 1027
15. O Iliopoulos A Kibel S Gray Jr KaelinWG 1995 Tumour suppression by the human von Hippel-Lindau gene product Nat Med 1 822 826
16. WG Kaelin 2002 Molecular basis of the VHL hereditary cancer syndrome Nat Rev Cancer 2 673 682
17. WY Kim WG Kaelin 2004 Role of VHL gene mutation in human cancer J Clin Oncol 22 4991 5004
18. EW Kuehn G Walz T Benzing 2007 Von Hippel-Lindau: a tumor suppressor links microtubules to ciliogenesis and cancer development Cancer Res 67 4537 4540
19. G Kurban E Duplan N Ramlal V Hudon Y Sado Y Ninomiya A Pause 2008 Collagen matrix assembly is driven by the interaction of von Hippel-Lindau tumor suppressor protein with hydroxylated collagen IV alpha 2 Oncogene 27 1004 1012
20. F Latif K Tory J Gnarra M Yao F-M Duh ML Orcutt I Kuzmin T Stackhouse W Modi L Geil L Schmidt F Zhou H Li MH Wei F Chen G Glenn P Choyke MM Walther Y Weng DR Duan M Dean D Glavac FM Richards PA Crossey MA Ferguson-Smith D Le Paslier I Chumakov D Cohen CA Chinault ER Maher B Zbar WM Linehan MI Lerman 1993 Identification of the von Hippel-Lindau disease tumor suppressor gene Science 260 1317 1320
21. L Li L Zhang X Zhang Q Yan YA Minamishima AF Olumi M Mao S Bartz WG Kaelin Jr 2007 Hypoxia-inducible factor linked to differential kidney cancer risk seen with type 2A and type 2B VHL mutations Mol Cell Biol 27 5381 5392
22. Z Li D Wang X Na SR Schoen EM Messing G Wu 2003 The VHL protein recruits a novel KRAB-A domain protein to repress HIF-1alpha transcriptional activity EMBO J 22 1857 1867
23. MS Lutz RD Burk 2006 Primary cilium formation requires von Hippel-Lindau gene function in renal-derived cells Cancer Res 66 6903 6907
24. ER Maher 2004 von Hippel-Lindau Disease Curr Mol Med 4 833 842
25. ER Maher JR Yates R Harries C Benjamin R Harris AT Moore MA Ferguson-Smith 1990 Clinical features and natural history of von Hippel-Lindau disease Q J Med 77 1151 1163
26. X Na HO Duan EM Messing SR Schoen CK Ryan PA di Sant'Agnese EA Golemis G Wu 2003 Identification of the RNA polymerase II subunit hsRPB7 as a novel target of the von Hippel-Lindau protein EMBO J 22 4249 4259
27. HP Neumann BU Bender DP Berger J Laubenberger W Schultze-Seemann U Wetterauer FJ Ferstl EW Herbst G Schwarzkopf FJ Hes CJ Lips JM Lamiell O Masek P Riegler B Mueller D Glavac H Brauch 1998 Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma J Urol 160 1248 1254
28. M Ohh RL Yauch KM Lonergan JM Whaley AO Stemmer-Rachamimov DN Louis BJ Gavin N Kley WG Kaelin O Iliopoulos WG Kaelin 1998 The von Hippel-Lindau tumor suppressor protein is required for proper assembly of an extracellular fibronectin matrix Mol Cell 1 959 968
29. KR Ong ER Woodward P Killick C Lim F Macdonald ER Maher 2007 Genotype-phenotype correlations in von Hippel-Lindau Disease Hum Mutat 28 143 149
30. A Schoenfeld EJ Davidowitz RD Burk 1998 A second major native von Hippel-Lindau gene product, initiated from an internal translation start site, functions as a tumor suppressor Proc Natl Acad Sci USA 95 8817 8822
31. KM Smits LJ Schouten BA van Dijk CA Hulsbergen-van de Kaa KA Wouters E Oosterwijk M van Engeland PA van den Brandt 2008 Genetic and epigenetic alterations in the von Hippel-Lindau gene: the influence on renal cancer prognosis Clin Cancer Res 14 782 787
32. AL Tong ZP Zeng HZ Li D Yang L Lu M Li YR Zhou J Zhang S Chen W Liang 2006 von Hippel-Lindau gene mutation in non-syndromic familial pheochromocy-tomas Ann N Y Acad Sci 1073 203 207
33. ER Woodward K Wall J Forsyth F Macdonald ER Maher 2007 VHL mutation analysis in patients with isolated central nervous system haemangioblastoma Brain 130 836 842
34. M Yoshida S Ashida K Kondo K Kobayashi H Kanno N Shinohara N Shitara T Kishida S Kawakami M Baba I Yamamoto M Hosaka T Shuin M Yao 2000 Germ-line mutation analysis in patients with von Hippel-Lindau disease in Japan: an extended study of 77 families Jpn J Cancer Res 91 204 212
35. B Zbar T Kishida F Chen L Schmidt ER Maher FM Richards PA Crossey AR Webster NA Affara MA Ferguson-Smith H Brauch D Glavac HP Neumann S Tisherman JJ Mulvihill DJ Gross T Shuin J Whaley B Seizinger N Kley S Olschwang C Boisson S Richard CH Lips M Lerman 1996 Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan Hum Mutat 8 348 357